Silencing UBE2C arrests cell cycle progression at the G1/S phases, inhibits cell proliferation in pancreatic ductal adenocarcinoma [34] and blocks the G2/M transition in melanoma [12]. Here, UBE2C is linked to pancreatic ductal adenocarcinoma.